4//SEC Filing
Virgin Herbert 4
Accession 0001209191-22-008208
CIK 0001706431other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 6:58 PM ET
Size
8.6 KB
Accession
0001209191-22-008208
Insider Transaction Report
Form 4
Virgin Herbert
EVP, Research & CSO
Transactions
- Exercise/Conversion
Common Stock
2022-02-08$1.53/sh+1,375$2,104→ 109,075 total - Sale
Common Stock
2022-02-08$33.94/sh−1,375$46,668→ 107,700 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-02-08−1,375→ 220,880 totalExercise: $1.53Exp: 2028-01-26→ Common Stock (1,375 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
- [F2]The option is fully vested and exercisable.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001786378
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 6:58 PM ET
- Size
- 8.6 KB